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Abstract
The transporter specificity of (99m)Tc-mebrofenin and ICG partially overlaps as both
compounds are transported by OATP1B3. (99m)Tc-mebrofenin is also taken up by OATP1B1,
whereas ICG is additionally transported by NTCP.
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Abstract
Background & aims: 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) and the indocyanine green 
(ICG) clearance test are used for the assessment of hepatic function before and after liver surgery. 
The hepatic uptake of 99mTc-mebrofenin and ICG is considered similar to the uptake of organic anions
such as bilirubin and bile acids. Little is known about hepatic uptake mechanisms of both compounds 
and recent evidence suggests that the hepatic transporters for ICG and 99mTc-mebrofenin are distinct. 
The aim of this study was to identify the specific human hepatic transporters of 99mTc-mebrofenin and 
ICG.  
Methods: The uptake of 99mTc-mebrofenin was investigated in cRNA-injected X. laevis oocytes 
expressing human OATP1B1, OATP1B3, OATP2B1, or NTCP. Chinese hamster ovary (CHO) cells 
stably expressing OATP1B1, OATP1B3, OATP2B1, or NTCP were used as a mammalian expression 
system. ICG transport into CHO cells was additionally imaged with confocal microscopy.  
Results: We demonstrated that OATP1B1 and OATP1B3 are involved in the transport of 99mTc-
mebrofenin. OATP1B1 showed an approximately 1.5-fold higher affinity for 99mTc-mebrofenin 
compared to OATP1B3. ICG is transported by OATP1B3 and NTCP. 
Conclusion: The transporter specificity of 99mTc-mebrofenin and ICG partially overlaps as both 
compounds are transported by OATP1B3. 99mTc-mebrofenin is also taken up by OATP1B1, whereas 
ICG is additionally transported by NTCP.
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Introduction
Preoperative evaluation of future remnant liver function is crucial in order to select patients with an 
increased risk for postoperative liver failure before major liver surgery or living donor liver 
transplantation. The indocyanine green (ICG) clearance test and technetium-99m (99mTc)-mebrofenin 
hepatobiliary scintigraphy (HBS) are valuable quantitative dynamic liver function tests used for the 
assessment of liver function before and after liver surgery(1-3). 
99mTc-mebrofenin is a 99mTc-labeled iminodiacetic (IDA) derivate originally used for the 
diagnosis of a multitude of biliary diseases(4) and since recently for the assessment of liver 
function(1). ICG is a tricarbocyanine dye that was first introduced to measure blood flow and later 
recognized as a useful compound for liver function testing(5). 99mTc-mebrofenin and ICG, both organic 
anions, are almost exclusively taken up by the liver and rapidly excreted into the bile without 
undergoing biotransformation and with no enterohepatic circulation(1,6). Although a similar 
hepatocellular uptake mechanism has been postulated, we recently demonstrated a significant 
difference between ICG and 99mTc-mebrofenin uptake profiles in a rat model of hepatic ischemia-
reperfusion injury(7), suggesting that the specific hepatic transporters for ICG and 99mTc-mebrofenin 
are distinct. The mechanisms underlying hepatocellular uptake of either compound have not yet been 
completely elucidated. 
The hepatic clearance of numerous organic anions, including drugs and xenobiotics, is mainly 
facilitated by the Na+-independent uptake by organic anion transporting polypeptides (OATPs)(8, 9) 
and organic anion transporters (OATs)(10). In human hepatocytes, OATP1B1, OATP1B3, and 
OATP2B1 isoforms are expressed at the basolateral plasma membrane of hepatocytes. In addition to 
OATs and OATPs, human Na+-taurocholate co-transporting polypeptide (NTCP), which constitutes the 
main uptake system for bile acids, has been shown to also transport some drugs in a Na+-dependent 
manner(11). The uptake of 99mTc-mebrofenin and ICG by any of these transporters is therefore 
probable. This is supported by the fact that bilirubin, sulfobromophthalein (BSP), and bile salts, which 
are OATP(12) and NTCP(13) substrates, inhibit the uptake of 99mTc-IDA agents(14, 15), suggesting 
that a common transport mechanism exists for these compounds and 99mTc-mebrofenin. Indirect 
evidence further suggests that ICG uptake is mediated by members of the OATP family, which is 
mainly based on the observation that ICG has the ability to inhibit the uptake of different OATP 
substrates(12).
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From a clinical perspective, an understanding of the hepatic uptake mechanisms of 99mTc-
mebrofenin and ICG is necessary for proper interpretation of both liver function tests under various 
conditions of liver disease. The aim of this study was therefore to identify the specific human 
hepatocellular transporters of 99mTc-mebrofenin and ICG. We hypothesized that specific members of 
the human OATP family or NTCP are involved in the uptake of both substances and that the specific 
transporters for 99mTc-mebrofenin and ICG are, at least in part, distinct. While our experiments were 
ongoing, a report was published that identified OATP1B1 and OATP1B3 as specific 99mTc-mebrofenin 
transporters(16). 
Materials and Methods 
Materials   Tritiated estrone-3-sulfate ([3H]E3S) and tritiated taurocholic acid ([3H]TC) were purchased 
from Perkin Elmer (Waltham, MA). Mebrofenin ((2,4,6-trimethyl-3-bromo)-iminodiacetic acid, Bridatec,
GE Healthcare, Chalfont St. Giles, UK) was labeled with 300MBq 99mTc in 1mL of 0.9% NaCl 
according to the manufacturer’s instructions, using the second eluate. Quality control was routinely 
performed to assure <5% free pertechnetate. ICG was purchased from PULSION Medical Systems 
(Munich, Germany). Cell culture media and antibiotics were obtained from Invitrogen (Carlsbad, CA) 
unless stated otherwise. L-proline and sodium butyrate were purchased from Sigma-Aldrich (St. Louis, 
MO)
Cell Lines   Chinese hamster ovary (CHO) cell lines stably expressing human OATP1B1, OATP1B3, 
and OATP2B1 have been described(17, 18). CHO wild type (CHO-WT) cells were used as control. 
Flp-In CHO cells stably expressing human NTCP were generated by ligating the coding sequence of 
NTCP into pcDNA5/FRT (Invitrogen, Carlsbad, CA) as described previously(19). Control cells were 
transfected with the empty pcDNA5/FRT vector (CHO-pcDNA5/FRT).
Cell Culture CHO-WT cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% fetal bovine serum, 50mM L-proline, and 100U/mL penicillin/streptomycin. The 
OATP1B1-, OATP1B3-, and OATP2B1-transfected CHO-cells were grown in DMEM containing 10% 
fetal calf serum, 0.05mg/mL L-proline, 100U/mL penicillin/streptomycin, and 500g/mL geneticin G-
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418(17, 18). Flp-In CHO cells (pcDNA5/FRT and NTCP) were grown in HAM F-12 medium containing 
10% fetal calf serum, 1mM L-glutamine, 100U/mL penicillin/streptomycin, and 500g/mL hygromycin 
B. Cells were incubated at 37°C in an atmosphere containing 5% CO2 and 95% humidity. For transport 
experiments, cells were seeded on 3.5-cm dishes. Transport experiments were performed 3-4d after 
seeding after confluence had been reached. To enhance the expression of the recombinant proteins, 
cells were induced with 5mM sodium butyrate 24h before the transport experiment.
99mTc-Mebrofenin Uptake in X. laevis Oocytes X. laevis ooctes were prepared as described 
before(20). In brief, 30 healthy oocytes were injected with 50nL of water or with 5ng of cRNA encoding 
human OATP1B1, OATP1B3, OATP2B1(21), or NTCP(22) in 50nL of water. After a 3-d culture, 10 
oocytes were pre-washed in uptake buffer and 99mTc-mebrofenin uptake was measured at 25°C in 
100μL of uptake solution (100mM NaCl, 2mM KCl, 1mM MgCl2, 1mM CaCl2, and 10mM HEPES, 
pH=7.5) for 30 and 60min. The functional expression of the OATPs and NTCP was verified with 
[3H]E3S and [3H]TC, respectively.
  
Transport of 99mTc-Mebrofenin and ICG in Stably Transfected CHO Cells Transport experiments 
were performed in OATP-expressing CHO cells and NTCP-expressing Flp-In CHO cells as described 
before(17, 20). Briefly, cells were washed 3× with pre-warmed (37°C) sodium buffer or choline buffer.
The uptake of 99mTc-mebrofenin in sodium or choline buffer was assayed at various predefined 99mTc-
mebrofenin concentrations in a 1-mL final volume. After incubation for 0-2min, the cells were washed 
4× with 2mL of ice-cold choline buffer and lysed with 1mL of 1% Triton-X100 (Fluka, Buchs, 
Switzerland) in PBS. A 500-μL aliquot was used for liquid scintillation counting. Protein concentrations 
were determined with the BCA assay (Thermo Fisher Scientific, Waltham, MA) using bovine serum 
albumin (BSA) as standard.  
Kinetic analysis for the uptake of 99mTc-mebrofenin was performed for a 0.25-5mM substrate 
concentration range. Cellular uptake rates were determined after normalization for incubation time and 
total protein content. Net uptake rates by OATPs and NTCP were calculated as the difference in the 
uptake rate of the transporter and controls, namely CHO-WT and CHO-pcDNA5/FRT, respectively, for 
each concentration. Kinetic parameters, Km and Vmax, were determined with nonlinear regression 
analysis using the Michaelis-Menten equation.
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  Transport experiments with ICG were performed as described above with the modification 
that, after incubation (0-5min) in ICG-containing sodium or choline buffer (0-200μM), cells were 
washed 4× with 2mL of ice-cold choline buffer containing 1% BSA followed by 4× washing with 2mL of 
ice-cold choline buffer. The cells were subsequently lysed with 300μL of 1% Triton-X100 in PBS. ICG 
concentrations were determined spectrophotometrically (Varioskan Flash, Thermo Fisher Scientific) at
805nm with the use of a standard curve. 
To confirm the antagonistic effect of ICG (ranging from 0-100μM) on OATP-mediated 
transport, [3H]E3S (5μM) was used as substrate for OATP1B1, OATP1B3, and OATP2B1 and [3H]TC 
(2.5μM) for NTCP. The uptake of [3H]E3S or [3H]TC was measured following 1min incubation. IC50
values were determined by plotting the log inhibitor concentration against the net uptake rate with 
nonlinear regression of the data set.
Confocal Laser Scanning Microscopy (CLSM)  CHO cells were grown on glass cover slips 
(Ø=25mm, Menzel-Gläzer, Braunschweig, Germany) for 3d until 50-60% confluence was reached. 
Cells were induced with 5mM sodium butyrate 24h before CLSM. The cells were washed 3× with pre-
warmed (37°C) sodium buffer and incubated with 1mL of ICG solution for 0, 2, or 5min. The cells were 
subsequently washed 4× with 2mL of ice-cold choline buffer containing 1% BSA, followed by 4× 
washing with ice-cold choline buffer. Cells were labeled with 1μM of carboxyfluorescein succinimidyl 
ester (CFSE, Invitrogen) for 5min, followed by 3× washing with ice-cold choline buffer. The cell 
nucleus was stained by incubating the cells with 0.01mg/mL 4',6-diamidino-2-phenylindole (DAPI, 
Invitrogen) for 10min, followed by 3× washing with ice-cold choline buffer. Cells were incubated for 
2min with propidium iodide (PI) to confirm cell integrity.  
CLSM was performed with an LSM 510 NLO confocal microscope (Carl Zeiss, Jena, 
Germany). Glass cover slips containing the cells were mounted in a metal ring system that was fitted 
in the temperature-controlled (37°C) translator stage of the microscope. PBS (1mL) was applied on 
the glass cover slip to prevent desiccation. ICG was excited with the 632.8-nm HeNe laser line and 
imaged through a 650-nm long pass emission filter. The 488-nm argon laser line was used in 
combination with a 525±25-nm band pass emission filter to visualize CFSE. DAPI was visualized in 
two-photon excitation mode using an 800-nm Ti:sapphire laser with a 425±35-nm band pass emission 
filter. PI was excited at 543nm and visualised using a 590±25-nm band pass emission filter.
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Data and Statistical Analysis Statistical analysis was performed with GraphPad Prism (GraphPad 
Software, San Diego, CA) and Statistical Package for Social Sciences (SPSS, Chicago, IL). IC50 and 
kinetic parameters were calculated using non-linear regression analysis in GraphPad Prism. Mann-
Whitney U tests were performed to compare two ordinal variables. Data are expressed as mean±SD. 
All statistical tests were two-tailed and differences were considered significant at a P-value of ≤0.05.
Results 
Transport of 99mTc-Mebrofenin in X. laevis Oocytes The uptake of 99mTc-mebrofenin (25μM) was 
first investigated in cRNA-injected X. laevis oocytes expressing human OATP1B1, OATP1B3, 
OATP2B1, or NTCP. As shown in Fig. 1, OATP1B1 and OATP1B3 transported 99mTc-mebrofenin 
whereas no transport was observed in OATP2B1 and NTCP. Uptake into control (water-injected) 
oocytes was negligible, indicating that no endogenous transport or diffusion of 99mTc-mebrofenin took 
place across the oocyte membrane.  
Uptake of 99mTc-Mebrofenin by Transfected CHO Cells  To exclude effects of the heterologous 
amphibian expression system on substrate specificity, transport experiments were repeated in a 
mammalian expression system. The OATP1B1- and OATP1B3-mediated transport of 99mTc-
mebrofenin was confirmed in OATP-expressing CHO cells (Fig. 2). At a concentration of 25µM, the 
uptake of 99mTc-mebrofenin into the OATP1B1-transfected cells was enhanced by more than 30-fold 
vs. uptake into CHO-WT cells (P<0.05), whereas the uptake by OATP1B3 was enhanced more than 
20-fold compared to the CHO-WT cells (P<0.05). Negligible transport was seen in the CHO-WT, 
OATP2B1-, and NTCP-transfected cells. Therefore, different expression systems do not affect the 
substrate specificity of the investigated transporters. 
Next, we investigated the time-dependence of 99mTc-mebrofenin (100µM) uptake into CHO 
cells expressing OATP1B1 and OATP1B3. The uptake of 99mTc-mebrofenin by OATP1B1 (Fig. 3A) 
and OATP1B3 (Fig. 3B) was linear up to 40 and 60s, respectively. The kinetic experiments were 
therefore performed using a 40-s incubation time.  
Fig. 4 depicts exemplary uptake kinetics for 99mTc-mebrofenin. The uptake was saturable with 
increasing concentrations of substrate for both OATP1B1- and OATP1B3-expressing cells. The 
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following Michaelis-Menten constants (Km) with associated maximum transport rates (Vmax) were 
calculated (derived from 3 independent experiments for each transporter): OATP1B1: Km=1.68±0.29 
mM, (Vmax=386nmol/mg protein/min) and OATP1B3: Km=2.57±0.85mM, (Vmax= 372nmol/mg 
protein/min). OATP1B1 exhibited a slightly higher affinity for 99mTc-mebrofenin than OATP1B3 with 
similar maximal transport rates.  
To correct for unknown transporter expression levels and to obtain an idea on individual 
transporter efficiency, the intrinsic clearance (Vmax/Km) was calculated. OATP1B1 had a 1.5-fold higher 
intrinsic clearance compared to OATP1B3 (0.23 vs. 0.14μL/min/μg protein).
Uptake of ICG by Transfected CHO Cells   CLSM demonstrated that OATP1B3 and NTCP were 
able to transport ICG (Fig. 5A, B). ICG was also taken up at low amounts by the CHO-WT cells as well 
as by OATP1B1, OATP2B1, and CHO-pcDNA5/FRT cells, which is suggested by the relatively low 
fluorescence intensity in the cytoplasm and the higher fluorescence intensity in perinuclear 
granules/vesicles (Fig. 6). In OATP1B3- and NTCP-transfected cells, the cytoplasmic ICG 
fluorescence was considerably higher (Fig. 5A, B) than in CHO-WT cells and cells expressing the 
other OATP isoforms. The absence of PI staining confirmed that the cells remained intact during the 
experiment (data not shown). 
Next, the extent of ICG uptake by OATPs and NTCP was quantified spectrophotometrically in 
transfected CHO cells (Fig. 7A, B). At a concentration of 50µM, the uptake of ICG after 1-min 
incubation increased twofold in OATP1B1-transfected cells compared to the CHO-WT cells.
Considerable background fluorescence was observed in the CHO-WT samples that was attributable to 
ICG adhering to the culture dish (not shown). OATP1B1- and OATP2B1-transfected cells exhibited a 
similar uptake to CHO-WT cells. The abovementioned background fluorescence made it difficult to 
determine transporter-specific kinetic parameters for ICG, as a result of which these data are not 
presented. The ICG uptake by NTCP-transfected Flp-In CHO cells was enhanced threefold after 1-min 
incubation compared to control (CHO-pcDNA5/FRT cells). The uptake of ICG by NTCP was 
significantly reduced when incubated in the absence of Na+, providing corroborative evidence for the 
involvement of NTCP in the Na+-dependent transport of ICG.
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Inhibition of OATP-Mediated Transport by ICG Earlier studies had demonstrated that ICG is an 
inhibitor of OATP-mediated transport(21,24). We therefore performed experiments to investigate the 
inhibitory potential of ICG on the uptake of [3H]E3S by OATPs and [3H]TC by NTCP. As shown in Fig. 
8, ICG was able to inhibit the uptake of [3H]E3S by all OATP isoforms. In addition, ICG inhibited the 
uptake of [3H]TC by NTCP. 
Discussion
Although ICG and 99mTc-mebrofenin are frequently used in clinical practice for the assessment 
of liver function, little is known about the hepatic uptake mechanisms of both agents. In this study we 
demonstrated that 99mTc-mebrofenin, an IDA derivative, is taken up into hepatocytes by OATP1B1 and 
OATP1B3 and that ICG is taken up by OATP1B3 and NTCP. 
Studies on the uptake of IDA derivates in cultured rat hepatocytes have evinced that IDA 
uptake is Na+-independent, temperature- and pH-dependent, and reduced in the presence of 
increasing bilirubin concentrations(15, 14). In addition, BSP, taurocholate, ICG, and Rose Bengal have 
been implicated as inhibitors of IDA uptake(14, 15), whereby the antagonistic effect of these 
compounds is highly dependent on the structure of the IDA agent. For instance, of all IDA agents,
99mTc-mebrofenin uptake is inhibited the least by bilirubin(14). Based on these findings it was 
concluded that, at least in part, the uptake of IDA derivates was similar to the uptake mechanism of 
bilirubin and BSP(4). A possible involvement of OATPs in the uptake of IDA derivates became evident 
after Jacquemin et al.(23) found that BSP and TC are taken up by OATP. The specific involvement of 
the OATP1B1 and OATP1B3 isoforms in the uptake of 99mTc-mebrofenin has recently been 
confirmed(16), but the possible role of the OATP2B1 isoform and NTCP were not considered and no
kinetics were calculated.
Our transport experiments in cRNA-injected X. laevis oocytes and transfected CHO cells 
corroborated that 99mTc-mebrofenin is transported by OATP1B1 and OATP1B3 and showed that 
OATP2B1 and NTCP are not involved in the uptake of 99mTc-mebrofenin. OATP1B1 exhibited an 
approximately 1.5-fold higher affinity and intrinsic clearance (Vmax/Km) for 99mTc-mebrofenin compared 
to OATP1B3, suggesting that OATP1B1 may be the preferential transporter for 99mTc-mebrofenin. 
Although the mM-range of Km implies a relatively low affinity for 99mTc-mebrofenin in comparison to 
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other OATP1B1 and OATP1B3 substrates(18, 24), the intrinsic transport capacities (Vmax/Km) of 
OATP1B1 and OATP1B3 indicate that the transport of 99mTc-mebrofenin is highly effective.
Similarly, indirect evidence that ICG is transported by members of the organic OATP family is 
mainly based on the observation that ICG is a well-known inhibitor of OATP-mediated transport(12).
Our study confirmed that ICG is a potent inhibitor of all investigated OATP isoforms and of NTCP. We
also demonstrated that only OATP1B3 and NTCP are involved in uptake of ICG, clearly indicating that 
the capacity of a compound to inhibit OATP-mediated transport does not necessarily coincide with its 
uptake by the respective OATP isoform, as was shown previously for drugs(17).
CLSM confirmed that OATP1B3 and NTCP facilitate ICG transport. Surprisingly, ICG was also 
taken up, albeit in low quantities, by CHO-WT cells, OATP1B1- and OATP2B1-transfected CHO cells, 
as well as by CHO-pcDNA5/FRT cells. Although ICG was diffusely present in the cytoplasm at low 
concentrations, it was enriched in perinuclear granules/vesicles. It is known that ICG is not exclusively 
taken up by hepatocytes, but also by reticulocytes, keratinocytes, and retinal pigment epithelial 
cells(25-27), whereby the intracellular localization of ICG in CHO-WT cells exhibited a similar granular 
pattern as reported for the other cell types. The significance of the vesicular accumulation and 
perinuclear localization of ICG in CHO-WT cells is presently unclear, but suggests that additional
mechanisms are involved. 
Hepatic ICG and 99mTc-mebrofenin uptake are impaired in cholestatic patients. OATPs have 
been implicated in the uptake of bilirubin(12), which might explain the competitive inhibition of 99mTc-
mebrofenin by high bilirubin concentrations(14). Nevertheless, the involvement of OATP1B1 and 
OATP1B3 in the uptake of bilirubin is controversial. Transport of bilirubin by OATP1B1 and OATP1B3 
has been demonstrated in cRNA-injected X. laevis oocytes, in which bilirubin uptake was significantly 
less efficient in OATP1B3 compared to OATP1B1(28). Similarly, OATP1B1 but not OATP1B3 was 
able to transport bilirubin in stably transfected human embryonic kidney cells (HEK293)(12).
Contrastingly, Wang et al.(29) precluded a physiological role for OATP1B1 in bilirubin transport. 
Therefore, the specific effect and exact mechanism of bilirubin on OATP-mediated transport remains 
elusive and warrants closer investigation. Besides increased plasma bilirubin levels, conjugated bile 
acids accumulate in plasma during cholestasis. Conjugated bile acids are predominantly transported 
by NTCP and it is therefore probable that bile salts inhibit the NTCP-mediated uptake of ICG during 
cholestasis. In addition, downregulation of uptake transporters during cholestasis may contribute to the 
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impaired uptake of ICG and 99mTc-mebrofenin(30). The specific effect of bilirubin and bile acids on 
OATP and NTCP-mediated transport of ICG and 99mTc-mebrofenin requires further investigation in 
light of the utility of 99mTc-mebrofenin HBS and the ICG clearance test as dynamic liver function tests 
in liver diseases where bilirubin and bile acid levels become aberrant.
Besides cholestasis, inflammation and drugs are known to influence the hepatic transport of 
several organic anions, including ICG and 99mTc-mebrofenin(31-34). Identification of the transport 
mechanisms of 99mTc-mebrofenin and ICG aids in the interpretation of both liver function tests under 
conditions of liver disease and liver regeneration. Cytokines such as TNF-α and IL-6 released by 
Kupffer cells in several liver diseases (e.g., steatosis and hepatitis) possibly affect the uptake of 99mTc-
mebrofenin in a different manner than ICG, as cytokines have a differential influence on the 
expression of different OATP isoforms and NTCP(30, 35-37). This differential response was confirmed 
in an in vivo rat model, which demonstrated that different stages of non-alcoholic fatty liver disease 
resulted in a differential decrease in several OATP and NTCP protein levels(38). Vetelainen et al. 
showed that the hepatic uptake of 99mTc-mebrofenin decreases with the severity of liver steatosis(39).
Furthermore, the abovementioned cytokines play an important role in ischemia-reperfusion injury as 
well as liver regeneration. We recently compared the ICG clearance test with 99mTc-mebrofenin HBS in 
rats after ischemia-reperfusion injury combined with a partial hepatectomy(7) and during liver 
regeneration after major hepatectomy(40). In both models a differential decrease in OATP isoforms 
was observed, contributing to the difference in hepatic uptake between ICG and 99mTc-mebrofenin
after ischemia-reperfusion injury and during regeneration.
In the final analysis, under normal conditions ICG and 99mTc-mebrofenin are considered to 
have high hepatic extraction ratios. The total hepatic clearance from the blood is therefore rate-limited 
by blood flow. It is now evident that several key uptake transporters are downregulated during liver 
disease, affecting the transport capacity and hepatic extraction. Hence the ICG clearance test and 
99mTc-mebrofenin HBS monitor not only blood flow but also the transport capacity. Given the high 
extraction of both compounds, it is likely that not the basolateral uptake systems but the canalicular 
export systems will become the clearance determining transporters under pathophysiological
conditions(41).Despite the relatively underexplored dynamics of blood flow and transport capacity 
under various pathophysiological conditions, the uptake and intracellular transit of  99mTc-mebrofenin 
and ICG represent clinically relevant hepatic function parameters insofar as their transport is similar to 
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various endogenous and exogenous substances such as bilirubin, bile acids, hormones, drugs, and 
toxins, whose uptake also relies on blood flow(31, 41). 
Conclusion 
The transporter specificity of 99mTc-mebrofenin and ICG partially overlap with both substances being 
transported by OATP1B3. 99mTc-mebrofenin is also transported by OATP1B1, whereas ICG is 
additionally taken up by NTCP. 
Legends  
Figure 1: Transport of 99mTc-mebrofenin in X. laevis oocytes. Uptake of 25µM 99mTc-mebrofenin was 
measured for 60 min. Uptake was observed only in cells expressing OATP1B1 and OATP1B3. Results 
are presented as mean±SD for n=10 oocytes per experiment.
Figure 2: Transport of 99mTc-mebrofenin in transfected CHO cells. Uptake of 25µM 99mTc-mebrofenin 
was measured after 1-min incubation, confirming the involvement of OATP1B1 and OATP1B3 in the 
uptake of 99mTc-mebrofenin. Results are presented as mean±SD for n=3 per experiment. 
Figure 3: Time-dependent transport of 99mTc-mebrofenin by OATP1B1- (A) and OATP1B3-transfected 
CHO cells (B). A 99mTc-mebrofenin concentration of 100µM was used. Results are presented as 
mean±SD for n=3 per experiment.
Figure 4: Michaelis-Menten plots of 99mTc-mebrofenin uptake into OATP1B1- (A) and OATP1B3-
expressing CHO cells (B) measured at 37°C for 40s. Following baseline subtraction (CHO-WT), the Km
and Vmax were derived from the Michaelis–Menten equation. Results are expressed as mean±SD of 
triplicate determinations from 3 independently performed transport experiments. 
Figure 5: Confocal microscopy images of CHO cells incubated for 2min with 50µM ICG. ICG was 
taken up by OATP1B3- (A) and NTCP-expressing cells (B). Intracellular ICG was predominantly 
located in the cytoplasm with occasional nuclear colocalization.  
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Figure 6: Confocal microscopy image of ICG (20µM, 2-min incubation) localization in perinuclear 
granules or vesicles of CHO-WT cells.  
Figure 7: The uptake of ICG by transfected CHO cells. After incubation for 1min, ICG (50µM)
transport was enhanced twofold in OATP1B3-transfected cells compared to CHO-WT (A). ICG (50µM)
transport into NTCP-transfected Flp-In CHO cells was enhanced threefold after 2min incubation 
compared to control cells (pcDNA5/FRT) (B). No transport of ICG by NTCP occurred in the absence of 
Na+ (choline buffer). Results are presented as mean±SD for n=3 per experiment.
Figure 8: ICG concentration-dependent inhibition of [3H]E3S uptake in OATP-expressing cells and 
[3H]TC in NTCP-expressing cells. ICG inhibited the uptake of competitive substrates in all transporter 
expressing cells at differential IC50 values. Note the disproportionally low IC50 value for OATP2B1 – a
transporter that did not facilitate ICG transport. Results are presented as mean±SD for n=3 per
experiment.
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